Coherus BioSciences Inc
F:8C5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coherus BioSciences Inc
F:8C5
|
US |
|
I
|
Iridium Communications Inc
F:6IC
|
US |
|
S
|
Sasol Ltd
JSE:SOLBE1
|
ZA |
|
A
|
Avnet Inc
XMUN:VNI
|
US |
|
A
|
Air Canada
SWB:ADH2
|
CA |
|
Ely Gold Royalties Inc
OTC:ELDCF
|
CA |
|
E
|
Equinix Inc
F:EQN2
|
US |
|
W
|
Wharf Real Estate Investment Company Ltd
F:4WF
|
HK |
|
C
|
CNH Industrial NV
F:37C
|
UK |
|
BP PLC
LSE:BP
|
UK |
|
C
|
Callaway Golf Co
XBER:CLY
|
US |
|
E
|
Empire Metals Ltd
F:NOGN
|
UK |
Wall St Price Targets
8C5 Price Targets Summary
Coherus BioSciences Inc
According to Wall Street analysts, the average 1-year price target for 8C5 is 4.57 EUR with a low forecast of 3.19 EUR and a high forecast of 5.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8C5's stock price target?
Price Target
4.57
EUR
According to Wall Street analysts, the average 1-year price target for 8C5 is 4.57 EUR with a low forecast of 3.19 EUR and a high forecast of 5.81 EUR.
What is the Revenue forecast for Coherus BioSciences Inc?
Projected CAGR
46%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 46%.
What is the Net Income forecast for Coherus BioSciences Inc?
Projected CAGR
6%
The compound annual growth rate for Net Income over the next 8 years is 6%.
